Oramorph (Morphine Sulfate Pentahydrate)

Morphine, the active ingredient in Oramorph, is an opioid analgesic presented as an oral formulation for oral use. It is employed to treat moderate to severe pain in adult patients when non‑opioid therapies are insufficient.\n\nGNH India supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine, an opioid analgesic, is used to manage pain across several clinical contexts.\n\n- Acute postoperative pain: provides effective relief after surgical procedures.\n- Cancer‑related pain: reduces severe pain associated with malignant diseases.\n- Chronic non‑cancer pain: alleviates persistent moderate to severe pain when other treatments are inadequate.\n- Severe traumatic injury pain: controls intense pain resulting from major injuries.

Morphine may cause a range of adverse reactions, varying from common to serious.\n\nCommon Side Effects:\n- Nausea: feeling of sickness or urge to vomit.\n- Constipation: reduced bowel movements and hard stools.\n- Drowsiness: increased sleepiness or sedation.\n- Dry mouth: reduced salivation leading to a parched sensation.\n\nSerious or Rare Side Effects:\n- Respiratory depression: slowed or shallow breathing that can be life‑threatening.\n- Severe hypotension: marked drop in blood pressure causing dizziness or fainting.\n- Dependence or addiction: risk of physical or psychological reliance with prolonged use.

When prescribing or dispensing morphine, several safety considerations should be observed.\n\n- Assess pain severity: ensure opioid therapy is appropriate for moderate to severe pain.\n- Evaluate respiratory function: monitor for depression, especially in opioid‑naïve patients.\n- Review concomitant CNS depressants: avoid or adjust dose when combined with benzodiazepines or alcohol.\n- Consider renal or hepatic impairment: dose may need adjustment in organ dysfunction.\n- Pregnancy and lactation: use only if benefits outweigh risks; consult obstetric guidance.\n- Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Morphine can interact with other medicines, altering its effects or safety profile.\n\nMajor Interactions (Avoid):\n- Concurrent use with other opioids: increases risk of respiratory depression.\n- Benzodiazepines or sedatives: additive central nervous system depression.\n- MAO inhibitors: may cause severe hypotension or serotonin syndrome.\n\nModerate Interactions (Monitor Closely):\n- Anticholinergic agents: may worsen constipation.\n- CYP3A4 inhibitors (e.g., ketoconazole): can raise morphine plasma levels.\n- Diuretics: may enhance hypotensive effect.